The Horizons Tracker

MARCH 15, 2021

As our society ages, the importance of self-care will only increase, so it’s perhaps no surprise that a recent report from pharmaceutical company GSK revealed that 80% of Europeans believe it’s their own responsibility to manage their health. Low investment in preventative healthcare.

Self-aware 83

Self-aware Pharmaceuticals Report System 83

Engaging Leader

APRIL 13, 2014

Workforce health engagement: improving the knowledge, decision-making, and behaviors of employees, their families, and organizational leaders to optimize health outcomes, control medical costs, and enhance workplace productivity. that optimize health outcomes and cost-effectiveness. Some employers, however, have […].

Health Care 138

Health Care Pharmaceuticals Long-term Education 138

HR Digest

FEBRUARY 1, 2022

They manage employee relations, recruit new employees, train them, and provide benefits. Other common employers include healthcare facilities, insurance providers, financial institutions, and pharmaceutical companies. How Do I Get Started As A Human Resources Manager? . The cost of human resources career path planning .

Career 98

Career Human Resources Licensing How To 98

Great Leadership By Dan

JUNE 14, 2018

When does pharmaceutical pricing become price gouging? When does cost saving become worker exploitation? One of the managers involved in the affair was an idealistic young man named Dennis Gioia, who went into the auto industry to make a contribution to society. When does online data harvesting become invasion of privacy?

Ethics 197

Ethics Maturity Analysis Cost-Benefit Analysis 197

N2Growth Blog

AUGUST 30, 2016

As you have likely heard, the pharmaceutical company Mylan and its CEO, Heather Bresch, have come under immense scrutiny for the firm’s EpiPen pricing policy. ” “The reality is and the brand pharmaceutical market, this isn’t an EpiPen issue. It costs something to develop the product. So $137 per pen.

Health Care 150

Health Care Pharmaceuticals Market Penetration Price 150

Tanveer Naseer

AUGUST 2, 2016

Last month, my oldest daughter Alya began working at her new summer job and now that she’s worked for two different companies over the past two summer periods, it’s been interesting to hear her observations about the differences in how her bosses manage their employees.

Pharmaceuticals 100

Pharmaceuticals Loyalty Learning-by-Doing Project 100

Eric Jacobson

JANUARY 15, 2016

Author Elaine Quinn wrote the book after working as a consultant for 10 years with small business owners who struggled with organization, time management, workflow processes, productivity and related challenges. The techniques Quinn teaches small home-based business owners also apply to work-from-home employees of large organizations.

Quinn 50

Quinn Pharmaceuticals How To Consultative 50

Eric Jacobson

DECEMBER 19, 2014

Author Elaine Quinn wrote the book after working as a consultant for 10 years with small business owners who struggled with organization, time management, workflow processes, productivity and related challenges. The techniques Quinn teaches small home-based business owners also apply to work-from-home employees of large organizations.

Quinn 61

Quinn Pharmaceuticals Consultative Skills 61

Harvard Business Review

NOVEMBER 15, 2018

This was because their expenses grew faster than their revenues, despite cost-cutting initiatives. Cost reduction requires an honest and thorough reassessment of everything the health system does and ultimately, a change in the organization’s operating culture. Barnacle removal is a key element of serious cost control.

Cost 10

Cost System Management Franchising 10

Eric Jacobson

DECEMBER 3, 2011

Author Elaine Quinn wrote the book after working as a consultant for 10 years with small business owners who struggled with organization, time management, workflow processes, productivity and related challenges. The techniques Quinn teaches small home-based business owners also apply to work-from-home employees of large organizations.

Quinn 56

Quinn Books Pharmaceuticals Consultative 56

Strategy Driven

JULY 13, 2011

While you can find numerous books focused on the topic of corporate finance, few offer the type of information managers need to help them make important decisions day in and day out. Examines ways to maintain and grow value through mergers, acquisitions, and portfolio management.

ROIC 62

ROIC Balanced Scorecard Metrics McKinsey 62

Harvard Business Review

JUNE 25, 2013

As part of HBR''s "Data Under Siege" Insight Center , we present a few charts that show just how quickly malicious attacks, and their costs, are mounting. Then there''s the cost issue: Malice has always been more costly than human or system error, and after a dip, its cost now appears to be rising yet again. IT management'

Cost 8

Cost Software Pharmaceuticals Health Care 8

Harvard Business Review

JANUARY 12, 2011

A few years ago, pharmaceutical giant sanofi-aventis sponsored an anonymous, Web-based survey of 4,200 workers at four health care, transportation, and manufacturing companies. Across the four companies, sleep-related reductions in productivity cost $54 million a year. Results from a survey of employees at several large U.S.

Cost 15

Cost Absenteeism Pharmaceuticals Survey 15

Lead on Purpose

SEPTEMBER 8, 2009

This consulting resource is none other than your employees – and it won’t cost you an extra cent to take advantage of their expertise and tap their limitless good will, because talk is cheap … All you have to do is ask! Unfortunately, my gesture was rebuffed and the union decided to strike.

Committee 140

Committee Automotive Ethics Productivity 140

Harvard Business Review

OCTOBER 29, 2012

If the cost of innovation is falling, that should enable more of it from poorer countries, companies or cooperatives. Those who say the cost is dropping often point to the dramatically falling costs of computing power. In fact, the costs of developing seminal software algorithms continue to rise, too.

Cost 8

Cost Innovation Wireless Disruptive Innovation 8

QAspire

JANUARY 24, 2010

He was a marketing executive with a large pharmaceutical company when he decided to pursue his calling and start a fitness center. Life Lesson on Endurance Other Links to this Post QAspire Blog - Quality, Management, Leadership & Life! with Phil Gerbyshak Management Craft Nicholas Bate NOOP.NL Don’t Kill It!

Directory 84

Directory Blog Pharmaceuticals Quality 84

Harvard Business Review

DECEMBER 27, 2016

Healthcare has become extraordinarily complex — the balance of quality against cost, and of technology against humanity, are placing ever-increasing demands on clinicians. A simple question was asked: are hospitals ranked more highly when they are led by medically trained doctors or non-MD professional managers?

Management 15

Management 360-Degree Feedback Mayo Training 15

Harvard Business Review

NOVEMBER 4, 2014

That means you may not get the drug your doctor wants to prescribe — or if you do, it will cost you a lot more money. In effect, more cost-effective medicines may be ranked lower in a formulary while less cost-effective drugs earn better slots. The fastest-growing costs in health care today are for specialty drugs.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

NOVEMBER 4, 2014

That means you may not get the drug your doctor wants to prescribe — or if you do, it will cost you a lot more money. In effect, more cost-effective medicines may be ranked lower in a formulary while less cost-effective drugs earn better slots. The fastest-growing costs in health care today are for specialty drugs.

Cost 8

Cost Committee Insurance Health Care 8

Harvard Business Review

APRIL 2, 2018

But a large reason why investments in health care underperform is because we invest so much in services that are clearly low-value — i.e., offer little or no clinical benefit relative to the cost — and likely many more where the returns are gray.

Health Care 8

Health Care Insurance Pharmaceuticals Incentives 8

Harvard Business Review

OCTOBER 23, 2017

Data science is becoming a reality for change management, and although it may not have arrived yet, it is time for organizations to get ready. Although predictive models for change management are still a ways off, organizations can get themselves on the right path by adopting the right tools and capturing the right data.

Company 8

Company Management Metrics Tools 8

Harvard Business Review

JULY 8, 2016

We in the West have long prided ourselves on our business process acumen, strategy savvy, and customer centricity while stereotyping Chinese competition as being nothing more than low cost. The first will be continued displacement by ever-more-competitive Chinese companies who compete on cost.

Business Model 10

Business Model Innovation Company Apparel 10

Harvard Business Review

MAY 26, 2016

That is good news for managers and investors. I account for the roles of R&D, spending on advertising and marketing, and on administrative costs, including IT. Indeed, critics of the regulatory state regularly decry the costs imposed by regulations. Profits are up. Corporate valuations are up as well.

Pharmaceuticals 11

Pharmaceuticals Politics Price Chemicals 11

Harvard Business Review

DECEMBER 14, 2017

It costs way too much ($3.3 This tends to focus doctors, nurses, and other health professionals on the value of what they do — finding the most cost-effective approach to managing their patients’ problems. Seamless teamwork is critical to effective care of complex, high-cost patients. Paul Taylor/Getty Images.

Health Care 8

Health Care System Insurance Pharmaceuticals 8

Strategy Driven

MARCH 18, 2011

This perspective is a shift from existing strategy perspectives as it affects nearly every major decision a company makes, from growth initiatives, portfolio strategy, and M&A opportunities to its approach to budgeting and cost cutting. SD : How can capabilities-driven strategy be applied to cutting costs? SD : Why now?

Resources 51

Resources Industry System Strategy 51

Harvard Business Review

SEPTEMBER 12, 2012

The study assembles considerable evidence about the hidden business model of major pharmaceutical companies: to devote most of their research budget to developing hundreds of drugs that provide few if any advantages over existing drugs and then market them heavily to doctors and patients. These cost employers even more in hidden ways.

Business Model 15

Business Model Company Pharmaceuticals Price 15

Chartered Management Institute

FEBRUARY 26, 2024

In a hazardous world, managers can learn from the world of scuba diving: train hard, because you’ll never get rid of risk Scroll for more Shortcut to start of content Gareth Lock, founder of The Human Diver. Want to learn more about what diving can teach managers about navigating risk? Additional reporting by David Waller.

Uncertainty 52

Uncertainty Risk Management Training Compliance 52

Harvard Business Review

OCTOBER 23, 2014

That’s why pharmaceutical, biotechnology, and medical device companies need to define their relevance in this new health care ecosystem, and soon. Risk and outcomes, as the scenario plays out, will be managed by predictive models, which are powered by machine learning algorithms that will improve their accuracy rates over time.

Health Care 8

Health Care Pharmaceuticals Information Technology Supply Chain 8

Harvard Business Review

FEBRUARY 29, 2016

But court rulings related to the second explosion found that cost cutting had proceeded, despite the safety risks. We then tested the model using quantitative data about the incidence of safety-related errors in the context of pharmaceutical drugs. Why do organizations forget what they learn, even when stakes are so high?

Organization 8

Organization McCombs Pharmaceuticals Learning-by-Doing 8

Harvard Business Review

NOVEMBER 8, 2017

But replicating the facility- and labor-intensive American model — which is more costly than that of any other nation yet produces subpar results — will set these emerging economies on the same course of endless cost escalation that has plagued the United States. Over the same period, pharmaceutical exports have doubled.

Health Care 8

Health Care Tourism Pharmaceuticals Cost 8

Harvard Business Review

JUNE 14, 2017

Like any number of industries, healthcare is being transformed by the explosion of low-cost data. Some firms have managed it, in healthcare and in other arenas — think of QuintilesIMS as a source of pharmaceutical sales data, Nielsen as the authority on TV viewer habits, and the U.S. There have been many benefits.

Health Care 9

Health Care Levitt Competitive Advantage Pharmaceuticals 9

Harvard Business Review

APRIL 3, 2017

And Capabilities and Management Systems act as a reality check on the Where to Play and How to Win choice. If you can’t identify a set of Capabilities and Management Systems that you currently have, or can reasonably build, to make the Where to Play and How to Win choice come to fruition, it is a fantasy, not a strategy.

First-mover Advantage 15

First-mover Advantage Retail Strategy Pharmaceuticals 15

Harvard Business Review

JANUARY 13, 2015

Do we ultimately compete on the basis of our cost structure (e.g., In pharmaceuticals, there are blockbuster drugs targeted at mass-markets segments. Soliris costs $400,000 per patient annually. Here, your cost structure allows you to sell and make money at prices that competitors cannot. billion in 2014.

Market Segmentation 8

Market Segmentation Mass Marketing Price Pharmaceuticals 8

Harvard Business Review

NOVEMBER 30, 2017

A few outlier industries (notably pharmaceuticals, medical devices, and computers) prop up the sector’s aggregate performance; most others have experienced flat growth or outright declines in real GDP over the past two decades. manufacturers do source from domestic suppliers, they tend to regard them purely as a cost center.

Supply Chain 8

Supply Chain McKinsey Incentives Bottom-up 8

Harvard Business Review

NOVEMBER 24, 2015

Joint value in combinations typically comes from one of four sources: increased scale, expanded scope, improvements in management coordination, and expansion of future options. The most common source of joint value is economies of scale , which allow for a reduction in the costs of either production or back-office operations.

Pharmaceuticals 8

Pharmaceuticals Cost Airlines Productivity 8

Harvard Business Review

APRIL 10, 2012

Would you put in time and effort in addition to the cost of a lottery ticket? Not long ago I listened to a senior executive in a pharmaceutical company talk to a team of managers about the limited availability of a particular medicine. However, what they didn't fully appreciate was the human cost.

Power 15

Power Pharmaceuticals Travel Cost 15

Harvard Business Review

DECEMBER 18, 2014

Now, because of ever-increasing financial stress and clinical demands, hospitals are engaging in deep forms of collaboration to reduce costs and improve outcomes for patients. It’s encouraging to see the creative collaboration hospitals are undertaking to reduce costs and improve outcomes.

Health Care 8

Health Care Retail Mayo Pharmaceuticals 8